Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rosali Maria Ferreira da Silva is active.

Publication


Featured researches published by Rosali Maria Ferreira da Silva.


Química Nova | 2007

Desenvolvimento de método analítico por CLAE em comprimidos de Benznidazol para a Doença de Chagas

Ana Luiza Maurer da Silva; José Lamartine Soares Sobrinho; Pedro José Rolim Neto; Rosali Maria Ferreira da Silva; Flávia Patrícia Morais de Medeiros; Leduar Guedes de Lima

The analytical method of high performance liquid chromatography (HPLC) for the assay of benznidazole in tablets was developed and validated following the requirements of regulatory agencies. The method used as mobile phase acetonitrile:wather 1:1, a C18 column of 12.5 cm length x 4 mm id, 5 mm particles and l=316 nm. The statistical analysis of the results demonstrated that the method satisfies all parameters so as to be considered a safe and efficient analytical alternative of low cost for laboratory routine.


Química Nova | 2008

Desenvolvimento e validação de método analítico para determinação simultânea de lamivudina, zidovudina e nevirapina em comprimidos dose-fixa combinada por cromatografia líquida de alta eficiência

Zênia Maria Maciel Lavra; Pedro José Rolim Neto; Rosali Maria Ferreira da Silva; Flávia Patrícia Morais de Medeiros

An analytical method has been developed and validated for the quantitation of lamivudine, zidovudine and nevirapine in the fixed-dose combination film-coated tablet by high performance liquid chromatography, in accordance with RE No. 899/2003, National Sanitary Surveillance Agency. It was based on an isocratic elution system with a potassium phosphate buffer pH 3.0: acetonitrile (60:40 v/v) mobile phase, C18, 250 x 46 mm column, 10µm particle size, λ 270 nm. The statistically evaluated results have shown that the method is specific, precise, accurate, and robust, ensuring the analytical safety of 3TC, AZT and NVP determination, which emerges as a new therapeutic alternative for antiretroviral treatment.


Revista Brasileira De Ciencias Farmaceuticas | 2006

Desenvolvimento de formulações e tecnologia de obtenção de comprimidos revestidos de efavirenz: terapia anti-HIV

Osnir de Sá Viana; José Benigno Júnior; Rosali Maria Ferreira da Silva; Flávia Patrícia Morais de Medeiros; Severino Grangeiro Júnior; Miracy M. Albuquerque; Pedro José Rolim Neto

Efavirenz is one of the most recent classes of anti-retroviral drugs used in the treatment of HIV infections. It is the first choice therapy for AIDS treatment. As efavirenz detains hydrofobic characteristic, low density and offers great resistance to draining, it has been essential to choose an adequated formulation for it, in order to guarantee drugs availability in gastro-intestinal tract, achieving bioavailability and expected therapeutical effects. This work presents efavirez coated tablets thecnological development, considering the physics and physico-chemical characteristics of this drug. The efavirez nucleus (tablets) has been obtained employing granulation technics by humid via. In the coating by film, Opadry Y-1-7000 in aquous system was used. The adopted parameters to tablet phisics evaluation followed official phamacopeial specifications and quantitative determination of the drug was performed by developed and validated methodology.


Acta Tropica | 2017

Schistosomiasis: Drugs used and treatment strategies

Lidiany da Paixão Siqueira; Danilo Augusto Ferreira Fontes; Cindy Siqueira Britto Aguilera; Taysa Renata Ribeiro Timóteo; Matheus Alves Ângelos; Laysa Creusa Paes Barreto Barros Silva; Camila Gomes de Melo; Larissa Araújo Rolim; Rosali Maria Ferreira da Silva; Pedro José Rolim Neto

Neglected tropical diseases (NTDs) affect millions of people in different geographic regions, especially the poorest and most vulnerable. Currently NTDs are prevalent in 149 countries, seventeen of these neglected tropical parasitic diseases are classified as endemic. One of the most important of these diseases is schistosomiasis, also known as bilharzia, a disease caused by the genus Schistosoma. It presents several species, such as Schistosoma haematobium, Schistosoma japonicum and Schistosoma mansoni, the latter being responsible for parasitosis in Brazil. Contamination occurs through exposure to contaminated water in the endemic region. This parasitosis is characterized by being initially asymptomatic, but it is able to evolve into more severe clinical forms, potentially causing death. Globally, more than 200 million people are infected with one of three Schistosome species, including an estimated 40 million women of reproductive age. In Brazil, about 12 million children require preventive chemotherapy with anthelmintic. However, according to the World Health Organization (WHO), only about 15% of the at-risk children receive regular treatment. The lack of investment by the pharmaceutical industry for the development and/or improvement of new pharmaceutical forms, mainly aimed at the pediatric public, is a great challenge. Currently, the main forms of treatment used for schistosomiasis are praziquantel (PZQ) and oxaminiquine (OXA). PZQ is the drug of choice because it presents as a high-spectrum anthelmintic, used in the treatment of all known species of schistosomiasis and some species of cestodes and trematodes. OXA, however, is not active against the three Schistosome species. This work presents a literature review regarding schistosomiasis. It addresses points such as available treatments, the role of the pharmaceutical industry against neglected diseases, and perspectives for treatment.


Revista Científica de Produção Animal | 2013

Estratégias para Uso de Cactáceas em Zonas Semiáridas: Novas Cultivares e Uso Sustentável das Espécies Nativas

Djalma Cordeiro dos Santos; Maria da Conceição Silva; J. C. B. Dubeux Júnior; Mário de Andrade Lira; Rosali Maria Ferreira da Silva

No Semiarido brasileiro, os anos mais secos do que a media historica de precipitacao tem se agrupado em periodos de tres a quatro anos e ocorrem a cada tres ou quatro decadas. Instabilidades estas que vem se acentuando nas ultimas decadas, tornando tambem instaveis os sistemas de producao agropecuario da regiao. Fato este que aumenta a importância de cultivo de forrageiras xerofilas nestas areas, entre elas destaca-se a palma forrageira. Diante disto e dos problemas fitossanitario que vem ocorrendo na regiao com esta cultura, crescente e a demanda por genotipos produtivos e adaptados para a referida regiao. Para atender tal demanda o Instituto Agronomico de Pernambuco/IPA em parceria com a Universidade Federal Rural de Pernambuco tem buscado por meio de seu Programa de Melhoramento da Palma Forrageira. Como resultado desse esforco pode-se citar a identificacao de novas cultivares de palma resistentes a praga cochonilha do carmim, as quais foram registrados no MAPA. Neste documento encontra-se a forma de obtencao desses novos genotipos, suas principais caracteristicas morfologicas e resultados preliminares de manejo das mesmas, bem como, de forma muito sucinta, a utilizacao de cactaceas nativas na alimentacao animal. DOI:10.15528/2176-4158/rcpa.v15n2p111-121


Revista Brasileira De Ciencias Farmaceuticas | 2008

Desenvolvimento e validação de método analítico para nistatina creme vaginal por cromatografia líquida de alta eficiência

Zênia Maria Maciel Lavra; Fabiane Sônego; Rosali Maria Ferreira da Silva; Flávia Patrícia Morais de Medeiros

Nystatin is a polyenic antibiotic with fungistatic and fungicide characteristics that acts by de-structuring the cellular membrane of fungi and yeast. The nystatin vaginal cream is used for the treatment of vaginal candidiasis. Until recently, the official compendia professed the microbiological trial for dosing this antibiotic, method considered as non-feasible in the routine of quality control centers due to the excessive time for release of results. Aiming at obtaining an alternative method for dosing nystatin vaginal cream, a chromatographic method (HPLC) was developed and validated. The method developed used a reversible phase column of C18, 3.9 x 150 mm, 4 mm, at 30 oC. The mobile phase was made up of a 0.25 mM sodium phosphate buffer and 0.025 mM EDTA, pH 6.00, methanol and acetonitrile (40:30:30), rate of 1.0 mL/minute and wavelength of 305 nm. The validated method showed to be accurate, precise, robust, linear and specific, in addition to being fast and practical, able to be used for analytic dosing of nystatin vaginal cream.


Revista Brasileira De Ciencias Farmaceuticas | 2007

Cápsulas de sulfato de indinavir: desenvolvimento farmacotécnico-industrial, desenvolvimento do método de dissolução e avaliação

Rosali Maria Ferreira da Silva; Fábio Henrique Cavalcanti de Oliveira; Clarice Madalena Bueno Rolim; Maria Fernanda Pimentel; Flávia Patrícia Morais de Medeiros; Miracy M. Albuquerque; Pedro José Rolim Neto

Indinavir sulfate is a protease inhibitor in the cycle of the human immunodeficiency virus (HIV). The purpose of this study was the development of formulation, and its evaluation methodology for dissolution, rheological study, scale transposition, stability study and comparative study for indinavir sulfate 500 mg capsules (equivalent to 400 mg of indinavir). A qualitative design of diluents has been performed for the pharmaceutics development. The analytical methodologies for medium weight, disintegration, humidity and uniformity of weight followed The United States Pharmacopeia 28, while the methodology used for dissolution was developed and evaluated in accordance with Resolution RE no 899, as of May 29, 2003, issued by the Agencia Nacional de Vigilância Sanitaria [National Agency for Sanitary Surveillance] (ANVISA). The results have evidenced that the selected formulation corresponds to the specifications of physical-chemical control, besides showing its economic feasibility. The results obtained from the development and evaluation of dissolution method have evidenced that the method complies with the requirements of Good Manufacturing and Control Practices, since it shows the reproducibility, the precision, the robustness and finally the reliability required for an analytical method. The developed indinavir sulfate capsules, when compared with the reference drug, are equivalent, in the light of different evaluated parameters.


Journal of Thermal Analysis and Calorimetry | 2009

THERMAL CHARACTERIZATION OF INDINAVIR SULFATE USING TG, DSC AND DSC-PHOTOVISUAL

Rosali Maria Ferreira da Silva; Flávia Patrícia Morais de Medeiros; Ticiano Gomes do Nascimento; R. O. Macêdo; Pedro José Rolim Neto


Revista de Ciências Farmacêuticas Básica e Aplicada | 2011

Atividade antimicrobiana de extratos etanólicos de Peperomia pellucida e Portulaca pilosa

L. P. M Mendes; K. M Maciel; A. B. R Vieira; L. C. Mendonça; Rosali Maria Ferreira da Silva; P.J. Rolim Neto; Wagner Luiz Ramos Barbosa; J. M. S Vieira


European Journal of Medicinal Chemistry | 2017

Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay

Jamerson Ferreira de Oliveira; Talitha Santos Lima; Débora Barbosa Vendramini-Costa; Sybelle Christianne Batista de Lacerda Pedrosa; Elizabeth Almeida Lafayette; Rosali Maria Ferreira da Silva; Sinara Mônica Vitalino de Almeida; Ricardo Olímpio de Moura; João Ernesto de Carvalho; Maria do Carmo Alves de Lima

Collaboration


Dive into the Rosali Maria Ferreira da Silva's collaboration.

Top Co-Authors

Avatar

Pedro José Rolim Neto

Federal University of Pernambuco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Larissa Araújo Rolim

Universidade Federal do Vale do São Francisco

View shared research outputs
Top Co-Authors

Avatar

Miracy M. Albuquerque

Federal University of Pernambuco

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Keyla E.R. da Silva

Federal University of Amazonas

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge